← FDA Drug Approvals (Drugs@FDA)
EMPAGLIFLOZIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AJANTA PHARMA LTD · Approved 2025-04-11
Drug application
- FDA Application #
ANDA217055- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EMPAGLIFLOZIN
- Generic name
- Empagliflozin
- Active ingredients
- EMPAGLIFLOZIN
- Dosage form
- TABLET
- Route
- —
- Marketing status
- None (Tentative Approval)
- Sponsor
- AJANTA PHARMA LTD
- First approval
- 2025-04-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown